The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption
- PMID: 9870708
- DOI: 10.1016/s0024-3205(98)00507-4
The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption
Abstract
In the present study, the effects of alprazolam, chlordiazepoxide, ethanol and haloperidol in the strychnine-potentiated startle response paradigm were investigated. Because strychnine increases control startle levels without fear-conditioning, no central state of fear exists. When anxiolytic drugs reduce the fear-induced potentiation of the startle response without reducing the strychnine-induced startle potentiation, their attenuating effect on startle potentiation in the fear-potentiated startle response paradigm can more likely be attributed to their anxiolytic properties. The selected drugs, which effectively reduced the fear-induced startle potentiation in an earlier study, indeed did not selectively affect the strychnine-induced startle potentiation, supporting the notion that the dose-dependent reduction of startle potentiation due to anxiolytic drugs in the fear-potentiated startle response paradigm does not reflect a "non-specific" disruption of startle behavior.
Similar articles
-
Fear-potentiated startle response is remarkably similar in two laboratories.Psychopharmacology (Berl). 1996 Jul;126(2):104-9. doi: 10.1007/BF02246344. Psychopharmacology (Berl). 1996. PMID: 8856828
-
Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs.Psychopharmacology (Berl). 1995 Mar;118(2):150-4. doi: 10.1007/BF02245833. Psychopharmacology (Berl). 1995. PMID: 7617801
-
The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.Behav Brain Res. 2018 Nov 1;353:57-61. doi: 10.1016/j.bbr.2018.06.035. Epub 2018 Jun 30. Behav Brain Res. 2018. PMID: 29969605
-
Pharmacological analysis of fear-potentiated startle.Braz J Med Biol Res. 1993 Mar;26(3):235-60. Braz J Med Biol Res. 1993. PMID: 8257926 Review.
-
Animal models of anxiety and anxiolytic drug action.Curr Top Behav Neurosci. 2010;2:121-60. doi: 10.1007/7854_2009_17. Curr Top Behav Neurosci. 2010. PMID: 21309109 Review.
Cited by
-
Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.Behav Brain Res. 2016 Jul 1;307:176-85. doi: 10.1016/j.bbr.2016.04.006. Epub 2016 Apr 6. Behav Brain Res. 2016. PMID: 27059335 Free PMC article.
-
An automatic recording system for the study of escape from fear in rats.Behav Processes. 2013 Nov;100:13-7. doi: 10.1016/j.beproc.2013.07.015. Epub 2013 Jul 30. Behav Processes. 2013. PMID: 23912122 Free PMC article.
-
Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.Pharmacol Biochem Behav. 2009 Mar;92(1):147-56. doi: 10.1016/j.pbb.2008.11.006. Epub 2008 Nov 17. Pharmacol Biochem Behav. 2009. PMID: 19041338 Free PMC article.
-
An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.Behav Pharmacol. 2009 Mar;20(2):184-94. doi: 10.1097/FBP.0b013e32832a8f66. Behav Pharmacol. 2009. PMID: 19322074 Free PMC article.
-
Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.Behav Pharmacol. 2009 Oct;20(7):584-95. doi: 10.1097/FBP.0b013e32832ec594. Behav Pharmacol. 2009. PMID: 19675456 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources